VeNaV Consulting

About VeNaV Consulting

VeNaV Consulting specializes in DMPK/PD strategy and operational consultancy, bridging the interfaces of Chemistry, Biology, and Pharmacology within Translational Medicine. Tailored to a global client base, services support Pharma, Biotech, medical device innovators, in vitro diagnostics (IVD), academic institutions, and NGOs. Core Services ▪ DMPK Strategy & Project Representation: Target assessment, hit/lead optimization, and clinical candidate characterization. Compilation and review of IND-enabling data packages, due diligence, and in/out-licensing support. ▪ Full-Cycle Study Management: End-to-end CRO workflow management under GxP guidelines. Covers in vitro/in vivo ADME (clearance, binding & distribution, metabolism & transporters, MetID), animal PK/TK, PK/PD, and other translational pharmacology. ▪ Foundational Modeling & Simulation Lean, fit-for-purpose human PK and dose predictions. Includes IVIVE, first-in-human (FIH) dose estimation, and drug-drug interaction (DDI) risk assessments. ▪ Early Clinical & Regulatory Support Early clinical PK oversight and basic contribution to clinical trial design. Contribution to regulatory filing packages for drugs (IB, IND, IMPD) and Medical Devices (MDR). Capabilities adapt to each project's specific requirements. Contact for tailored, expert program support: consulting@venav.org